KTC
NVO

Kentucky Trust Company’s Novo Nordisk NVO Stock Holding History

Kentucky Trust Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Hold
5,250
– – 0.12% 106
2026
Q1 		$193K Hold
5,250
– – 0.1% 111
2025
Q4 		$267K Sell
5,250
-400
-7% -$20.5K 0.14% 99
2025
Q3 		$314K Hold
5,650
– – 0.17% 95
2025
Q2 		$390K Hold
5,650
– – 0.22% 84
2025
Q1 		$392K Sell
5,650
-100
-2% -$8.26K 0.23% 84
2024
Q4 		$495K Buy
+5,750
New +$622K 0.29% 72

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Kentucky Trust Company's NVO Position: Q2 2026 in Review

Kentucky Trust Company held its Novo Nordisk (NVO) position steady in Q2 2026 at 5,250 shares worth $252K. The position accounts for 0.12% of the portfolio, ranked #106.

Kentucky Trust Company first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $495K in Q4 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Kentucky Trust Company held 5,250 shares of Novo Nordisk worth $252K as of Q2 2026.
  • Kentucky Trust Company left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.12% of Kentucky Trust Company's portfolio in Q2 2026, its #106 holding.
  • Kentucky Trust Company first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • Kentucky Trust Company's Novo Nordisk position peaked at $495K in Q4 2024.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Kentucky Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.